Cargando...
A Granulomatous Drug Eruption Induced by Entecavir
Entecavir (Baraclude®, Bristol-Myers Squibb) is a potent and selective antiviral agent that has demonstrated efficacy in patients with chronic hepatitis B. The most frequent adverse events attributed to entecavir include increased alanine aminotransferase, upper respiratory tract infection, headache...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3870221/ https://ncbi.nlm.nih.gov/pubmed/24371400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2013.25.4.493 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|